Multidrug Resistant CTX-M-Producing Escherichia coli: A Growing Threat among HIV Patients in India
Table 1
VAGs/characteristics among the CTX-M producers () and nonproducers ().
VAGs/resistance
Number (%) of strains positive for the VAG/characteristic
ESBL producers ()
CTX-M producers ()
Non-CTX-M producers ()
p value
pap
19 (33.3)
16 (40)
3 (17.7)
0.1833
sfa/foc
1 (1.8)
0 (0)
1 (5.9)
0.6564
afa/dra
3 (5.3)
2 (5)
1 (5.9)
0.8914
iutA
32 (56.1)
24 (60)
8 (47.1)
0.5425
fyuA
45 (78.9)
32 (80)
13 (76.5)
0.7649
iroN
20 (35.1)
15 (37.5)
5 (29.4)
0.7779
kpsMII
21 (36.8)
18 (45)
3 (17.7)
0.0486
usp
19 (33.3)
11 (27.5)
8 (47.1)
0.2602
Haemolysis
3 (5.3)
2 (5)
1 (5.9)
0.8914
AmpC
54 (94.7)
40 (100)
14 (82.4)
0.0374
CIP
47 (82.5)
37 (92.5)
10 (58.8)
0.0037
SXT
57 (100)
40 (100)
17 (100)
1
GEN
38 (66.7)
30 (75)
8 (47.1)
0.0818
CIPSXTGEN
35 (61.4)
28 (70)
7 (41.2)
0.0403
VAGs: virulence associated genes, CIP: resistant to CIP, SXT: resistant to SXT, GEN: resistant to GEN, and CIPSXTGEN: multidrug resistance. , odds ratio: 3.8182, and 95% CI: 0.9473 to 15.389. , odds ratio: 32.3665, and 95% CI: 2.607 to 401.8328. , odds ratio: 8.6333, and 95% CI: 1.8839 to 39.5634. , odds ratio: 3.3333, and 95% CI: 1.0252 to 10.8382.
